PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
Corporate Actions

Alembic Pharmaceuticals Limited

In PositoAI's records, Alembic Pharmaceuticals Limited has had 6 dividends since 2021 (₹66 per share in total). Latest dividend: ₹12 per share, ex-date 29 Jul 2026.

Records start: dividends 2021, bonus and rights issues 2016, splits and buybacks 2022, mergers and demergers 2025. Earlier actions are not shown.

Alembic Pharmaceuticals Limited Dividend History#

Ex-dateDividendRecord dateAnnounced
2026₹12 per share
29 Jul 2026₹12 per share29 Jul 202615 May 2026
2025₹11 per share
29 Jul 2025₹11 per share29 Jul 20256 May 2025
2024₹11 per share
15 Jul 2024₹11 per share15 Jul 20249 May 2024
2023₹8 per share
28 Jul 2023₹8 per share28 Jul 20235 May 2023
2022₹10 per share
17 Aug 2022₹10 per share18 Aug 20222 May 2022
2021₹14 per share
19 Jul 2021₹14 per share21 Jul 20214 May 2021

Amounts are per share as declared, not adjusted for later bonus issues or splits.

Questions

Does Alembic Pharmaceuticals Limited pay dividends?

Yes. In PositoAI's records (from 2021), Alembic Pharmaceuticals Limited has paid 6 dividends, the latest ₹12 per share with ex-date 29 July 2026.

How much dividend did Alembic Pharmaceuticals Limited pay in 2025?

₹11 per share in 2025, in 1 payment.

What is an ex-date and a record date?

To receive a dividend, bonus or other benefit, you must own the shares before the ex-date. The record date is the day the company checks its list of shareholders.

Records: dividends from 2021, bonus issues and rights issues from 2016, splits and buybacks from 2022, mergers and demergers from 2025; new actions are added every day. Amounts are per share in rupees. To receive a dividend or bonus, shares must be held before the ex-date. Please confirm dates with the company's own announcement. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.